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11.1  Personal Reflections 
 It was started by the Nobel prize-winning Professor Sir Joseph Rotblatt in 1960 as 
a Radioisotope department with Ms McAlister and Mr Laurie Hawkins as Physicists. 
I was appointed by the Chief of Radiology Dr Ian Kelsy-Fry as Consultant Physician 
in charge of the Nuclear Medicine Department in 1976. My aim was to set up an 
open, friendly and welcoming clinical, teaching and research department in spite of 
the poor physical environment and initially only one gamma camera. It was mainly 
equipped through various grants including one from the St Barts Trustees and not 
by the NHS. I was also appointed as Consultant Physician in acute General Medicine 
with ward beds, ‘on take’ twice a week, Outpatients and Hypertension Clinic and 
with students to teach. After I was made Professor of Nuclear Medicine, I continued 
with the Hypertension Clinic but with no further ward duties. We had excellent 
Physicist support with Messrs Alex Elliot, Cyril Nimmon, Melvyn Carroll, Ravin 
Sobnack and for therapy Ms Ro Foley; and innovative Pharmacy support with Mr 
Stephen Mather and Mr Kishor Solanki and their staff. Mr Jagdish Mistry led the 
dedicated technical staff with Ms Nishamalie Fenando. We introduced and were the 
fi rst to use the Hermes system in the UK. 
 The three main infl uences that helped determine the teaching, research and staff-
ing were the International Atomic Energy Agency, IAEA, the Imperial Cancer 
Research Fund, ICRF, later renamed Cancer Research UK and the European 
Association of Nuclear Medicine, EANM. 
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11.2  IAEA 
 For 25 years, I undertook between one to three annual mainly teaching missions 
abroad for the IAEA in many different countries. As a result and with their support 
over 100 post-graduate doctors from overseas came to us. They undertook and almost 
all passed the MSc of the University of London. They are mostly now Heads of 
Nuclear Medicine departments around the world, for example Drs Mike Rutland in 
New Zealand, Simon Gruenewald in Australia, Vaseem Chengazi in USA, Husein 
Kartamihardja in Indonesia, Ng Chensiew in Malaysia, Kerim Sonmezoglu in Turkey 
and Mirek Dzuik in Poland; and in the UK, included Dr Jamshed Bomanji, who was 
our longest and most active resident, Dr now Professor Sobhan Vinjamuri, Dr Hikmat 
Jan and Dr Lorenzo Biassoni. Several British residents and many other short and 
longer term visitors including Dr now Professor Adil Al Nahhas joined us. 
Commonwealth scholars also made their mark including Professor Ajit Padhy who 
became Head of Life Sciences at the IAEA. There were 9 PhDs doctorates on differ-
ent aspects of the department’s research. Among other innovative work, Kishor 
Solanki and I developed Infection imaging with Tc-99m Ciprofl oxacin ‘Infecton’. 
Ciprofl oxacin binds specifi cally to dividing bacteria including Mycobacteria. It was 
patented through the government’s British Technology Group, BTG (now a stock 
market quoted company). The IAEA supported a multi-centre study in eight coun-
tries from Indonesia to Argentina. Over 1000 patients were recruited. The results 
were excellent and published by the IAEA and elsewhere. Infecton was taken over by 
the Canadian company DraxImage. Kishor Solanki subsequently joined the IAEA. 
11.3  IRCF 
 Dr Marie Granowska joined the department in 1976 supported by the Wellcome 
Foundation to develop non-invasive measurement of Cerebral Blood fl ow in ml/min 
using Tc-99m Albumin or Red Cells with Cyril Nimmon’s computer programmes. 
She showed that Cerebral Blood fl ow improved in Professor John Lumley’s patients 
with carotid artery disease after extra-cranial intra-cranial bypass surgery. 
 The ICRF supported her to undertake clinical research using the monoclonal 
antibodies which they provided and which Steve Mather radio-labelled. She contin-
ued at St Barts becoming a Reader in Nuclear Medicine of the University of London, 
except for 1 year when she was locum Consultant at the Middlesex Hospital in 
1981, while Dr now Professor Peter Ell was in Berne. ICRF also supported techni-
cal staff notably Ms Sally Bentley and Mr Greg Morris, based with her at St Marks 
Hospital. Her research there with Professor John Northover using Tc-99m PR1A3 
successfully detected recurrent colorectal cancer prior to surgery. 
 Her studies using Tc-99m HMFG1 or SM3 with Professor John Shepherd in 
Ovarian cancer and with Mr Rob Carpenter in Breast cancer were benefi cial. Impalpable 
but involved axillary nodes were demonstrated prior to surgery. The analysis was aided 
by Cyril Nimmon’s Probability Mapping computer programmes. All this work was 
presented at international meetings and published in peer- reviewed journals. 
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 In-111 PSMA from Cytogen Corp. USA was fi rst used by us in Europe to evalu-
ate Prostate cancer recurrences with Mr Vinod Nargund. Applying Melvyn Carroll’s 
advanced image analysis, the results were very encouraging and now Ga-68 PSMA 
is being introduced more widely. 
11.4  EANM 
 It was created partly through Professor Erkki Vauramo’s ‘Sauna diplomacy’ at the 
Finnish European Congress in 1984. The presidents of the two existing societies, the 
Society of Nuclear Medicine, Europe, SNME and the European Society of Nuclear 
Medicine, ESNM were incarcerated in the hot Sauna until they had reached a provi-
sional agreement. As President of the SNME, I chaired a subsequent ‘Linking 
Committee’, a long meeting between the senior offi cers of the two societies. A draft 
constitution separating the powers of National Delegates and individual Members was 
initiated and I proposed the name. The fi rst joint meeting of the two societies was held 
in 1985 at the Barbican Arts Centre, London, when I was Congress President and led 
the organising committee. We expected 1200 and over 3000 participants came. Ms 
Sue Hatchard, Secretary of the BNMS and her team organised the registration and 
paper work, Dr Ralph McCready sorted out the exhibition and the Trade Unions; Dr 
Reg Jewkes dealt with the fi nances, Dr Peter Ell took us to the theatre to see 42nd 
Street, Dr Keith Harding was front of house and Dr Andrew Hilson made the music 
happen for the opening ceremony with the Right Honourable Edward Heath, the 
speaker in the interval. He spoke of how Europe was like the Orchestra, made up of 
many nationalities and instruments, yet working together harmoniously – times have 
changed! We had dinner in the Great Hall of St Bartholomew’s Hospital, Fig.  11.1 .
 ‘25 years of the EANM’, contains a facsimile of the original contract. Clause 4 
states that ‘The European Association of Nuclear Medicine is founded in London at 
the European Nuclear Medicine Congress 1985 by the signatories of the contract’ 
of whom I was one of the four, two from each Society. This makes our 1985 
Congress in effect the fi rst EANM meeting, even if it was not so titled. 
11.5  Other Collaborative Work 
 Oncology with Professor Andrew Lister and Neuroendocrinology tumours, NETs, 
with Professor G. Michael Besser allowed us to develop or use new therapeutic 
agents. One of the most risky was the manufacture in house of I-131 MIBG for 
imaging and therapy. It required a 150 °C oil bath and large amounts of liquid I-131. 
It was undertaken by Laurie Hawkins and Dr Tipha Horne. We administered Y-90 
Octreotide and Y-90 Lanreotide for NETs and Y-90 Bexxar anti-Lymphoma anti-
body for Non-Hodgkins disease. At St Marks we used P-32-PR1A3 for hepatic 
artery infusion for liver metastases with Angiotensin II administered to constrict the 
normal vessels; and intravenous P-32 labelled non-specifi c antibody at St Barts to 
target the bone marrow for the treatment of Polycythaemia. 
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 Fig. 11.1  The Great Hall at St Bartholomew’s Hospital, set for dinner and overseen by Holbein’s 




 Cardiology was keenly developed with Dr Duncan Dymond. We had the fi rst 
multi-crystal Baird Atomic camera in the UK. Most daring was using Gold Au-195m 
(Half-life 31 s) eluted from a Mercury column with dilute Cyanide, real alchemy! 
Alex Elliott was the brave volunteer for the fi rst injection with Methylene Blue 
standing by. The fi rst pass images showed beautiful, moment by moment, cardiac 
contraction and relaxation. The short half-life enabled repeat imaging every few 
minutes. 
 Myocardial Perfusion studies with SPECT followed and in 2 years we earned £1 
million for the Trust for patients coming in from around the region. The administra-
tors said we were charging too much to their customers and made us charge less 
than the cost of the procedure. Of course they then complained when we were over 
budget. There is no space to go into the troubles caused by administrators, I will just 
record that when I arrived there was one administrator to four nurses, when I left 
there were four administrators to one nurse. When I arrived there were over 800 
beds, when I left there were under 400. As a result there were patients on trolleys in 
passages by Casualty waiting for beds. We Physicians called them ‘Bottomley’ 
wards after the Right Honourable Mrs Virginia Bottomley, who tried to close St 
Barts. She failed due to the courageous efforts of Professor Michael Besser and 
Dame Lesley Rees. 
11.6  The Present and Future 
 I was made to retire due to age 65 in 2004. After a year’s interregnum presumably 
to save the hospital money, Dr Norbert Avril was appointed in 2005 for his PET 
experience. A PET/CT, which I had requested, arrived in 2008 after a 5 year delay. 
Dr then Professor Avril ran it. He left in 2012. Dr Hikmat Jan, who had done the 
MSc with us in 1997 was appointed Clinical Lead. The research and postgraduate 
students returned with his enthusiasm. Dr Hikmat Jan and Ms Margaret Newell, 
Lead Physicist at the Royal London Hospital, designed the new department. It was 
opened at St Barts in 2014 in the basement of the totally new building behind the 
King George V frontage, a listed building. 
 The clinical staff became jointly responsible for the Nuclear Medicine at the 
Royal London Hospital after the long and excellent reign of Dr Neil Garvie, who 
retired in 2007. Recently they provide a service for Whipps Cross and Newham 
Hospitals and thus serve four sites. These are fully equipped with 7 gamma cameras 
in total with the one PET/CT at St Barts and are linked through a Hermes system. 
 The current Consultant staff are: Doctors Hikmat Jan, Lead Nuclear Medicine 
Physician, Lorenzo Biassoni, Ewa Nowosinska, Nuclear Medicine Physicians, 
Athar Haroon, Ayshea Hameeduddin, Yen Zhi Tang, Arman Parsai, Nuclear 
Medicine/Radiologists. A further Consultant Nuclear Medicine/Radiologist is due 
to be appointed in September 2015. They are supported by Chief Pharmacist Dr 
Neil Hartman from 2003 and his staff (now supplying six hospitals) and Lead 
Physicist Mrs Margaret Newell from 1976 with her staff and an excellent body of 
technologists. There are in training six Radiology registrars and three Foundation 
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Year 2 doctors. The annual work load has increased to over 4000 Myocardial 
Perfusion Studies and more than 2400 PET/CT. There is a growing SPECT/CT 
demand with the other general Nuclear Medicine procedures. New therapies include 
Lu-177 Dotatate for NETs, Radium-223 for bone metastases and Y-90 Theraspheres 
for liver tumours by intra hepatic artery infusion, while the traditional Iodine-131 
based therapies continue. 
 Under its present active leadership, Nuclear Medicine in the St Barts and the 
London Trust is thriving and blossoming. 
 Keith Britton MSc MD FRCR FRCP 
 Emeritus Professor, University of London 
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